Attention for sex in COVID-19 trials: a review of regulatory dossiers
An under-representation of women and a lack of sex-specific analyses in COVID-19 trials has been suggested. However, the higher number of men than women who are severely affected by COVID-19 and the restricted information in scientific publications may have biased these suggestions. Therefore, we ev...
Main Authors: | Sieta T de Vries, Peter G M Mol, Harald Enzmann, Viktoriia Starokozhko, Ingrid M M Schellens, Leonoor Wijnans, Marco Cavaleri |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-03-01
|
Series: | BMJ Global Health |
Online Access: | https://gh.bmj.com/content/7/3/e008173.full |
Similar Items
-
Precision medicine in regulatory decision making: Biomarkers used for patient selection in European Public Assessment Reports from 2018 to 2020
by: Elisabeth Bakker, et al.
Published: (2023-11-01) -
Effectiveness of MF59™ adjuvanted influenza A(H1N1)pdm09 vaccine in risk groups in the Netherlands.
by: Leonoor Wijnans, et al.
Published: (2013-01-01) -
Bell's palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series.
by: Leonoor Wijnans, et al.
Published: (2017-01-01) -
Current european regulatory perspectives on insulin analogues
by: Enzmann Harald G, et al.
Published: (2011-07-01) -
Introducción dossier = Dossier Introduction
by: Gabriela de Lima Grecco, et al.
Published: (2019-07-01)